Compare Illumina, Inc. (ILMN) vs Sibanye Stillwater Ltd (SBSW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Sibanye Stillwater Ltd — how do they compare? Illumina, Inc. trades at $269.34 (market cap $39.95B), while Sibanye Stillwater Ltd trades at $10.02 (market cap $6.88B). The key difference: Illumina, Inc. is far larger — about 5.8× Sibanye Stillwater Ltd's market cap, and Sibanye Stillwater Ltd pays a 8.17% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Sibanye Stillwater Ltd for 51 Days on average.
| ILMN | SBSW | |
|---|---|---|
Market Cap | $39.95B | $6.88B |
Volume | 3,169,503 | 4,474,536 |
Sector | Health | Basic Materials |
52-Week High | $293.69 | $21.12 |
52-Week Low | $91.00 | $8.00 |
Typical Hold Time | 83 Days | 51 Days |
Enterprise Value | $41.31B | $7.78B |
Dividend Yield | — | 8.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $267.76, down 2.11% today but remains near recent highs after a strong 94.9% YTD rally. The stock shows bullish technical momentum with recent earnings beats and improved profitability, with net income turning positive to $850 million in 2025 after previous losses. S&P 500 inclusion in September 2026 and growing AI integration in genomics provide positive catalysts, though valuation metrics remain elevated with a P/E of 49.36.
Outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI adoption, while risks include China headwinds, margin pressure, and high valuation multiples requiring sustained execution to justify premium pricing.
SBSW trades at $9.68, down 3.3% today, amid a bearish technical outlook. The stock shows mixed earnings with a recent Q2 2026 beat but a Q4 2025 miss. Fundamentals reflect strong revenue growth projected to $164.9B in 2026 and attractive valuation ratios, including a P/E of 8.12 and EV/EBITDA of 4.09, though net income was negative in 2025. Cash flow trends improved significantly in 2025, turning net positive. Analyst sentiment is moderately bullish with a $14.25 consensus target.
The outlook hinges on execution of its growth roadmap and commodity price stability. Upside potential exists from operational momentum and disciplined capital allocation, but risks include debt levels, volatile earnings, and macroeconomic pressures on mining sectors. The stock presents a value opportunity if profitability rebounds as projected.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →
